Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...

c Includes CHD or CHD risk equivalent, 10-y risk >20%. d Includes ≥2 risk factors, 10-y CHD risk 10-20%. e Includes ≥2 risk factors, 10-y CHD risk <10%. f Includes 0-1 risk factors.

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

AstraZeneca’s corporate headquarters were chosen to be in London, United Kingdom, while its R&D headquarters were to ... including Crestor (rosuvastatin calcium), plendil (felodipine) and ...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...

Feb. 3, 2025 — Maternal vitamin D levels in the first trimester were related to both prenatal growth and pregnancy outcomes, according to a new study. Low vitamin D levels during the first ...

Gross Margin: 84% in Q1 2025. Core R&D Costs: Increased by 16%, representing 23% of total revenue. Core SG&A Costs: Increased by 4%. Core Operating Profit Margin: 35%. Core Tax Rate: 16% in Q1 2025.

Statin use in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma is associated with improved cancer survival outcomes.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Despite decades of research establishing the safety and efficacy of cholesterol-lowering medications, adherence remains a ...

Lifestyle changes, like switching up fat sources in your diet or adding more exercise to your weekly routine, may help reduce “bad” LDL cholesterol. If those changes aren’t enough ...